Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis

Mult Scler. 2013 Dec;19(14):1938-42. doi: 10.1177/1352458513485654.

Abstract

Emerging evidence underlines the importance of micro(mi)RNAs in the pathogenesis of multiple sclerosis (MS). Free-circulating miRNAs were investigated in serum from MS patients compared to controls. Statistically significant decreased levels of miR-15b, miR-23a and miR-223 were observed in MS patients (p < 0.05). Results were validated and replicated in two further independent MS populations. A direct correlation between miRNA levels and the EDSS score was determined in PPMS (p < 0.007). The generalized trend toward miRNA down-regulation could result in over-expression of target genes involved in disease pathogenesis. Circulating miRNA profiling could thus represent a new avenue to identify easily detectable disease biomarkers.

Keywords: Multiple sclerosis; biomarkers; demyelination; microRNA; serum.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Case-Control Studies
  • Disability Evaluation
  • Down-Regulation
  • Female
  • Genetic Markers
  • Humans
  • Male
  • MicroRNAs / blood*
  • Middle Aged
  • Multiple Sclerosis, Chronic Progressive / blood
  • Multiple Sclerosis, Chronic Progressive / diagnosis
  • Multiple Sclerosis, Chronic Progressive / genetics*
  • Multiple Sclerosis, Relapsing-Remitting / blood
  • Multiple Sclerosis, Relapsing-Remitting / diagnosis
  • Multiple Sclerosis, Relapsing-Remitting / genetics*
  • Predictive Value of Tests

Substances

  • Genetic Markers
  • MIRN15 microRNA, human
  • MIRN223 microRNA, human
  • MIRN23a microRNA, human
  • MicroRNAs